NCT02154659

Brief Summary

Gastroesophageal reflux disease is increasing worldwide. The causes of reflux symptoms are not found exactly. especially, the postprandial reflux symptoms are more common than the all day reflux symptoms. One of the causes of reflux symptoms is the relaxation of the lower sphincter of the esophagus. But, the sphincter relaxation also occur in normal people. But, there is a difference in postprandial reflux pattens between the patients and the normal people. So, in this study, we want to compare the difference of reflux pattern between the patients who have postprandial reflux symptoms and normal people though the 24hr pH monitoring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2014

Completed
2 days until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2015

Completed
Last Updated

March 18, 2019

Status Verified

March 1, 2019

Enrollment Period

1.5 years

First QC Date

May 30, 2014

Last Update Submit

March 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • The difference of reflux pattern at postprandial period between the patients who have postprandial reflux symptoms and the normal people

    Primary Outcome - The difference of reflux pattern at postprandial period between the patients who have postprandial reflux symptoms and the normal people The postprandial reflux symptom means that the symptoms more than once for a week for more than 1 month

    Within the 24 hours after the 24hr pH monitoring

Secondary Outcomes (1)

  • The difference of esophageal reflux pH between the patients who have postprandial reflux symptoms and the normal people

    Within the 24 hours after the 24hr pH monitoring

Study Arms (2)

postprandial reflux group

OTHER

Esophageal pH monitoring is the current gold standard for diagnosis of gastroesophageal reflux disease. It provides direct physiologic measurement of acid in the esophagus and is the most objective method to document reflux disease, assess the severity of the disease and monitor the reflux acidity.

Device: 24hr pH monitoring

normal group

OTHER

Esophageal pH monitoring is the current gold standard for diagnosis of gastroesophageal reflux disease. It provides direct physiologic measurement of acid in the esophagus and is the most objective method to document reflux disease, assess the severity of the disease and monitor the reflux acidity.

Device: 24hr pH monitoring

Interventions

normal grouppostprandial reflux group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • over 19 years old, male and female
  • normal people (control group, who has no postprandial reflux symptoms
  • patients who have postprandial reflux symptoms (postprandial reflux symptom means that within the last 6 months, postprandial reflux symptoms more than once a week for more than 1 month)

You may not qualify if:

  • patients who have nasoesophageal stricture
  • patients who have bleeding tendency
  • patients who have esophageal varix
  • patients who have cardioverter implantation
  • patients who had surgery for esophagus, stomach or duodenum
  • patients who are taking medications, gastrointestinal motility drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yonsei university College of Medicine

Seoul, South Korea

Location

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2014

First Posted

June 3, 2014

Study Start

June 1, 2014

Primary Completion

December 7, 2015

Study Completion

December 7, 2015

Last Updated

March 18, 2019

Record last verified: 2019-03

Locations